Home › Trial NCT00538031
Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Trial IDNCT00538031
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorCity of Hope Medical Center
- Enrollment52
- Start date2003-12-22
- ConditionsFallopian Tube Cancer · Peritoneal Cavity Cancer · Recurrent Ovarian Epithelial Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.